PubMed Health⌕ Search

Biomedical subjects

N J Rothwell

Publications and source records attributed to N J Rothwell.

At least 163 records · Page 9Linked to original sources

Opposing effects of activation of central GABAA and GABAB receptors on brown fat thermogenesis in the rat.

Baclofen (a GABAB agonist) stimulates body temperature, metabolic rate and brown adipose tissue (BAT) in the rat through a central action, but no effects of gamma-aminobutyric acid (GABA) itself on these parameters were observed. In the present study, it was found that the central effects of (+/-)baclofen (0.5-2.0 micrograms injection i.c.v.) on the temperature (1.2 degrees C increase) and metabolic rate (44-76% increase) of brown adipose tissue were inhibited by previous treatment with the GABAA agonist, muscimol (0.05 micrograms). Injection of GABA alone (12 micrograms) did not significantly affect these parameters, but in the presence of the GABAA antagonist bicuculline (2.5 micrograms), GABA significantly increased the temperature (0.3 degrees C) and oxygen consumption (22%) of brown fat. (-)Baclofen was found to be approximately 50-times more effective in stimulating the temperature of brown adipose tissue than (+/-)baclofen. The results indicate that activation of central GABAB receptors stimulates the activity and hence metabolic rate of brown adipose tissue. However, activation of the GABAA receptors opposes the effects of GABAB stimulation on the thermogenesis of brown fat.

Adipose Tissue, Brown↗

Chronic inhibition of GABA transaminase results in activation of thermogenesis and brown fat in the rat.

1. Oral administration of the GABA transaminase inhibitor ethanolamine-O-sulphate (EOS, 5 mg/ml in drinking water) to rats for 14 days suppressed food intake by 24%, but reduced weight gain by over 35%. 2. Thus, feed efficiency (g gain/MJ eaten) was decreased by over 15% in EOS-treated rats, suggesting that there had been an increase in metabolic rate. 3. The thermogenic response (rise in oxygen consumption, VO2) to injection of noradrenaline was enhanced by 50% and the thermogenic activity of brown adipose tissue (BAT, assessed from mitochondrial GDP-binding) was increased by 38% in EOS-treated rats. 4. Injection of baclofen (a GABAB agonist, 0.5 mg/kg s.c.) stimulated VO2 in both groups, with a significantly greater response in EOS treated rats, and this was enhanced by bicuculline (GABAA antagonist, 0.5 g/kg s.c.) in control rats and attenuated by muscimol (GABAA agonist, 0.5 mg/kg s.c.) in control and EOS-treated rats. 5. The data indicate that increasing brain GABA concentrations with EOS results in lower levels of metabolic efficiency and increases in thermogenesis.

4-Aminobutyrate Transaminase↗

Changes in body composition, brown adipose tissue activity and thermogenic capacity in BN/BiRij rats undergoing senescence.

Metabolic rate, thermogenesis, brown adipose tissue (BAT) activity, and body composition were followed in ageing rats (female BN/BiRij) at 3 to 35.5 months of age. Colonic temperatures were similar in rats at 3 to 23 months of age (37.1-37.6 degrees C), but significantly reduced (36.3 degrees C) in those aged 36 months. Resting oxygen consumption (VO2), corrected for body size, was comparable in all groups, but the thermogenic response to noradrenaline was significantly reduced with age. BAT mass was unaffected by age, but brown fat protein content, specific mitochondrial cytochrome oxidase activity, and thermogenic activity (assessed from mitochondrial purine nucleotide binding) all declined markedly with age. Carcass analysis revealed a fall in body protein in very old (35.5 month) rats, but body fat content increased up to 23 months of age and thereafter declined.

Adipose Tissue, Brown↗

Increased body-weight gain and body protein in castrated and adrenalectomized rats treated with clenbuterol.

1. Daily injection of the beta 2-adrenergic agonist clenbuterol (1 mg/kg body-weight) increased weight gain by 12% in young (35 d) male rats and by 18% in castrated rats, but had no effect on energy intake, expenditure or efficiency in either group. 2. Body fat content was not affected by clenbuterol or castration, but water and protein content were significantly increased by clenbuterol treatment in both intact and castrated rats. The ratio, body protein: fat was increased by 13 and 16% in these two groups compared with their respective, untreated controls. 3. Bilateral surgical adrenalectomy (ADX) of young (45 d) male rats significantly reduced body-weight, and energy intake, expenditure and efficiency. Carcass energy and fat contents were also reduced in ADX rats compared with age-matched controls. 4. Clenbuterol injections stimulated weight gain (% increase:intact 15, ADX 35), and increased body protein content (% increase:intact 12, ADX 8) and the ratio, carcass protein:fat (% increase:intact 34, ADX 23). 5. These findings demonstrate that the effects of clenbuterol on body-weight gain and composition in male rats occur in the absence of either gonadal or adrenal hormones. Together with other studies, these results provide further evidence to suggest that clenbuterol probably exerts its effects by a direct action on lean body mass.

Adrenalectomy↗

The cafeteria diet as a tool for studies of thermogenesis.

The cafeteria diet involves feeding experimental animals a choice of palatable human food items to stimulate energy intake, and has been used extensively to study diet-induced thermogenesis. In a recent commentary Moore has argued that this feeding regime is inappropriate for such studies because the nutrient composition cannot be controlled, many of the effects seen are due to protein or nutrient deficiency and accurate measurements of energy intake are difficult to achieve. We argue that all of these criticisms can be overcome by careful use of the feeding regime and well-controlled experiments. Gross nutrient composition of cafeteria diets can be modified over a wide range, and such studies demonstrate that the effects of protein deficiency can be clearly dissociated from those of hyperphagia. There is no experimental evidence for nutritional deficiency in cafeteria-fed animals even over very long periods of time. Furthermore, the alternatives suggested by Moore, i.e., presenting sucrose solutions to drink or high fat diets, suffer the same drawbacks of altered and often uncontrolled nutrient intake and yet produce little or no increase in energy intake. Criticism of the cafeteria diet is not justified simply because of its misuse by nutritionally naive experimenters. The value and validity of this feeding regime is further supported by the enormous impact it has made on our understanding of energy balance regulation and thermogenesis.

Animals↗

Thermogenic effects of dihydrocodeine in the rat.

The object of this study was to assess the effects of dihydrocodeine on thermogenesis and brown adipose tissue activity in the rat from measurements of oxygen consumption and blood flow. Acute injection of dihydrocodeine tartrate (s.c.) stimulated resting oxygen consumption (VO2) in Sprague-Dawley rats in a dose-dependent manner (0.5-50 mg/kg), with a peak response (40-45% increase) occurring at 10-25 mg/kg. This effect was also observed in urethane-anaesthetized rats (although the effect was reduced) and in conscious animals following gastric intubation with the drug. Pretreatment of rats with either a beta-adrenergic antagonist (propranolol, 20 mg/kg), ACTH (4 g/kg), or an opiate antagonist (WIN44441-1, 2 mg/kg) significantly reduced the response to dihydrocodeine, whereas corticosterone injection (5 mg/kg) enhanced the effect. Surgical adrenalectomy or hypophysectomy (HYPX) almost completely abolished the thermogenic effect of dihydrocodeine. Dihydrocodeine also stimulated VO2 in lean (58% increase) and genetically obese Zucker rats (69% increase), and in both Zucker genotypes these responses were only slightly affected by HYPX, but enhanced in HYPX rats treated daily with corticosterone (1 mg/kg). Tissue blood flow, assessed from the distribution of radiolabelled microspheres, was unaffected in white adipose tissue, skeletal muscle, testes, kidney, brain, and liver (arterial supply) after a single injection of dihydrocodeine (25 mg/kg), but flow to interscapular and perirenal brown adipose tissue was increased by 9- to 10-fold. Surgical sympathectomy of brown adipose tissue prevented the increase in blood flow.(ABSTRACT TRUNCATED AT 250 WORDS)

Adipose Tissue, Brown↗

Effect of hypophysectomy on energy balance and brown fat activity in obese Zucker rats.

Hypophysectomy (HYPX) in genetically obese (fa/fa) Zucker rats significantly reduced body weight and energy gains and stimulated energy expenditure (by 34%), the thermic response to food (by 144%), and brown adipose tissue (BAT) mitochondrial GDP-binding capacity (by 190%) compared with pair-fed, sham-operated obese rats. These changes in energy balance in obese HYPX rats were reversed by corticosterone replacement (1 mg/day), but the increased BAT activity was only partly restored to normal. HYPX had only small effects on energy balance in lean Zucker rats compared with pair-fed, sham-operated lean controls but increased the acute thermic response to food and BAT mitochondrial GDP-binding capacity; these effects were inhibited by replacement of HYPX rats with corticosterone. The results suggest that alterations in the hypothalamic-pituitary-adrenal axis play a fundamental role in the development and maintenance of genetic obesity.

Adipose Tissue, Brown↗

Involvement of sympathetic nervous system and brown fat in endotoxin-induced fever in rats.

The object of this study was to assess the role of brown adipose tissue (BAT) and the sympathetic nervous system in the rise in heat production associated with endotoxin-induced fever. Oxygen consumption (VO2) was found to be significantly increased (28%) over a 4-h period after two doses of endotoxin (Escherichia coli lipopolysaccharide, 0.3 mg/100 g body wt) given 24 h apart. Injection of a mixed beta-adrenoceptor antagonist (propranolol) reduced VO2 by 14% in endotoxin-treated rats, whereas the selective beta 1- (atenolol) or beta 2- (ICI 118551) antagonists suppressed VO2 by 10%. These drugs did not affect VO2 in control animals. BAT thermogenic activity assessed from measurements of in vitro mitochondrial guanosine 5'-diphosphate (GDP) binding was elevated by 54% in interscapular BAT and by 171% in other BAT depots. Surgical denervation of one lobe of the interscapular depot prevented these responses. Endotoxin failed to stimulate GDP binding in rats fed protein-deficient diets. This may have been because BAT thermogenic activity was already elevated in control rats fed these diets or because endotoxin caused a marked suppression of food intake in the protein-deficient animals. The results indicate that sympathetic activation of BAT is involved in the thermogenic responses to endotoxin and that these can be modified by dietary manipulation.

Adipose Tissue, Brown↗

Insulin and thermogenesis.

The evidence reviewed here indicates that insulin can increase sympathetically-mediated thermogenesis, probably via its central actions. However, since hypoglycaemia appears to inhibit thermogenesis, the interpretation of data and design of the experiments to study this phenomenon are highly problematic and further confounded by marked changes in insulin sensitivity. This review has purposely concentrated on work performed on experimental animals without directly referring to man. This is because of the very limited number of studies carried out in man, and the fact that difficulties of interpretation discussed above are multiplied many-fold by the limitations of human studies. The evidence to support a role for DIT in energy balance regulation and the importance of brown fat in man has been reviewed elsewhere. A limited number of studies have reported increases in metabolic rate in human subjects infused with glucose and insulin. This response is partially inhibited by the beta-adrenergic antagonist propranolol, and the effects diminished in some grossly obese subjects (e.g. Pima Indians). Landsberg has recently presented and discussed data which indicate that insulin can stimulate thermogenesis in man, and concluded that 'insulin is a major signal that relates dietary intake to sympathetic activity'.

Adipose Tissue, Brown↗

Changes in thermogenesis and brown fat activity in response to tumour necrosis factor in the rat.

A single intravenous injection of recombinant human tumour necrosis factor (TNF) resulted in significant, but transient (24-48 hr) reductions in food intake and body weight, and increases in rectal temperature, resting oxygen consumption (VO2) and brown adipose tissue (BAT) thermogenic activity (mitochondrial GDP-binding). The increased VO2 was inhibited by beta-adrenergic blockade (propranolol), and activation of BAT was prevented by denervation of the tissue. In adult (4-month old) animals, TNF induced greater reductions in food intake and body weight, caused general malaise and some fatalities, but did not significantly alter VO2 or BAT activity. However, the reduction in VO2 following beta-adrenergic blockade was greater in TNF-treated rats and BAT activity was enhanced when compared to pair-fed controls. Injection of adult rats with gamma-interferon induced small changes in body weight and temperature which were slightly potentiated when injected with a low dose of TNF. The results indicate that TNF stimulates sympathetic outflow to BAT. This effect may be partly responsible for the increases in body temperature and metabolic rate associated with TNF treatment and with cancer cachexia.

Adipose Tissue, Brown↗

Effect of a selective beta 2-adrenergic agonist (clenbuterol) on energy balance and body composition in normal and protein deficient rats.

In rats fed a normal (22% protein) diet, injection of clenbuterol (1 mg/kg/d for 21 d) did not affect energy intake, energy expenditure or weight gain, but reduced energetic efficiency, and fat and energy gains and increased body protein content. Presenting a low-protein (8%) diet reduced energy intake, gain and efficiency, body protein content and the mass of the gastrocnemius muscle when compared to rats fed the control diet. Injection of the protein-deficient rats with clenbuterol (1 mg/kg/d for 21 d) caused hypophagia and reduced body weight and energy gains, energy expenditure and total body fat. However, the total body content of protein was not significantly reduced and the percentage of body protein in this protein deficient, clenbuterol-treated group was greater than that of untreated rats on both the high- and low-protein diets. The ratio of body protein to fat following clenbuterol treatment was increased by over 50% in both normal and protein-deficient rats. The results show that in protein deficient animals, clenbuterol treatment may help conserve body protein at the expense of fat, resulting in a smaller, but leaner body mass.

Animals↗

Stimulation of thermogenesis and brown fat activity in rats fed medium chain triglyceride.

Gastric intubation of young male rats with 100 kJ/d of medium chain (C8 and C10) triglyceride (MCT) reduced their voluntary intake of stock diet such that total metabolizable energy intake was similar to that of rats intubated with water, and 41% of their energy intake was derived from MCT. Body weight, energy gain, and energetic efficiency were all markedly suppressed in MCT-fed rats, but energy expenditure over the 14-day experiment was significantly increased. Resting oxygen consumption, measured at thermoneutrality, was also enhanced in MCT-fed rats, but this difference was abolished by injection of the animals with the beta-adrenergic antagonist, propranolol. Brown adipose tissue mass was similar for both groups, but the activity of the mitochondrial proton conductance pathway, assessed from the binding of purine nucleotides, was increased by over 70%. These data indicate that the reduced weight gains of animals fed MCT are due to elevated rates of energy expenditure, possibly resulting from sympathetic activation of brown fat thermogenesis.

Adipose Tissue, Brown↗

Activation of brown fat thermogenesis in response to central injection of corticotropin releasing hormone in the rat.

Injection of CRF-41 (2-5 nmol) into the third ventricle, or the paraventricular nucleus of anaesthetized rats caused a marked rise in the temperature of the interscapular brown adipose tissue (BAT) depot (peak rise 0.8-1 degree C) which was inhibited by prior intravenous injection of propranolol. There was also a significant increase in the mitochondrial proton conductance pathway of brown adipose tissue, assessed from the binding of guanosine diphosphate (GDP) to mitochondria isolated from the interscapular (89% above control) and perirenal and para-aortic depots (130%). Acute surgical sympathectomy of interscapular brown adipose tissue immediately prior to injection of CRF significantly attenuated the increase in mitochondrial GDP-binding. Hypophysectomized (HYPX) rats showed a large (180%) increase in GDP-binding of brown adipose tissue 7 days after surgery and this was almost completely prevented by denervation of the interscapular depot prior to hypophysectomy. Acute injection of morphine also reduced the GDP-binding in hypophysectomized, but not in control rats. These data demonstrate that central injection of CRF stimulates thermogenesis in brown adipose tissue, probably by modifying sympathetic outflow. The activation of brown adipose tissue following hypophysectomy was also dependent on the sympathetic innervation and could be due to an increase in release of CRF.

Adipose Tissue, Brown↗

Effects of ciglitazone on energy balance, thermogenesis and brown fat activity in the rat.

Young male rats were treated with vehicle or ciglitazone (150 mg/kg/day, intragastric) for 8 or 14 days. Drug treatment did not affect food intake but reduced body weight and energy gains over 14 days, and significantly depressed energetic efficiency. Energy expenditure and resting oxygen consumption (VO2), when corrected for body size, were elevated in ciglitazone-treated rats, but the difference in VO2 was abolished by treatment of the animals with a beta-adrenergic antagonist (propranolol). The acute thermic response (postprandial rise in VO2) to a fat meal was similar for both groups, but the response to carbohydrate ingestion was greater in ciglitazone-treated rats (18%) than controls (11.5%). The mass of interscapular brown adipose tissue was not affected by drug treatment, but its protein content was increased and its thermogenic activity (mitochondrial purine nucleotide binding) was elevated by 25% after chronic treatment with ciglitazone. These results indicate that ciglitazone enhances thermogenesis via sympathetic activation of brown adipose tissue, probably as a result of improved insulin sensitivity.

Adipose Tissue, Brown↗

Influence of carbohydrate and fat intake on diet-induced thermogenesis and brown fat activity in rats fed low protein diets.

Voluntary intake of protein, fat and carbohydrate (CHO) was modified by feeding young rats either a control purified diet [% metabolizable energy (ME): protein 21, fat 7, CHO 72], a control diet plus sucrose solution (20%) to drink (final intakes 17, 6 and 77% ME as protein, fat and CHO, respectively) or a low protein diet substituted with either CHO (8, 7 and 85% ME as protein, fat and CHO, respectively) or fat (8, 20 and 72% ME as protein, fat and CHO, respectively). Total ME intakes corrected for body size were similar for all rats, but body weight, energy gain and net energetic efficiency were lower in both low protein-fed groups than in the control group. The acute thermogenic response (% rise in oxygen consumption) to a standard balanced-nutrient meal was higher (12%) in sucrose-supplemented and in low protein groups (15-16%) than in control rats (8%). Brown adipose tissue protein content and thermogenic capacity (assessed from purine nucleotide binding to isolated mitochondria) were greater than control values in sucrose-fed and protein-deficient animals, and the greatest levels of activity were seen in low protein-fed rats with a high fat intake. The results demonstrate that the changes in energy balance, thermogenesis and brown adipose tissue activity that result from protein deficiency cannot be ascribed to changes in the level of energy intake or to a specific increase in the amount or proportion of either CHO or fat. They suggest that the protein-to-energy ratio must be the primary influence on thermogenesis and brown fat activity in these animals.

Adipose Tissue, Brown↗

Effect of environmental temperature on energy balance and thermogenesis in rats fed normal or low protein diets.

Rats fed a low protein (9% metabolizable energy) diet and housed at 24 degrees C gained less weight and body energy then controls fed a normal (25%) protein diet. Energy intake and expenditure corrected for body size [kJ/(kg0.75 X d)] were similar in rats fed the two diets, but energetic efficiency was suppressed in low protein-fed rats, and the thermogenic response to norepinephrine and the activity of brown adipose tissue (mitochondrial GDP binding) were both significantly elevated. Housing at a higher temperature (29 degrees C) suppressed energy expenditure and brown fat activity in animals fed either diet, and gross efficiency was greater in control animals at 29 degrees C than at 24 degrees C but unaffected in the protein-deficient group. The differences in brown fat activity between dietary groups were still apparent at 29 degrees C. The results suggest that thermogenesis induced by feeding low protein diets is not markedly inhibited by a higher environmental temperature.

Adipose Tissue↗

Changes in tissue blood flow and beta-receptor density of skeletal muscle in rats treated with the beta2-adrenoceptor agonist clenbuterol.

Rats injected with the beta2-adrenoceptor agonist clenbuterol (2 mg kg-1 per day) for 18 days gained significantly more weight than controls. Tissue blood flow assessed 24 h after the last injection from the distribution of radiolabelled microspheres was increased in white (5 fold) and brown (3 fold) adipose tissue of clenbuterol-treated rats but was unaffected in kidney, brain and diaphragm, and was reduced by about 80% in skeletal muscle. Acute injection of clenbuterol one hour before measuring blood flow, increased blood flow to brown fat (20 fold) in both treated and control groups. Blood flow to skeletal muscle increased more in the rats treated chronically with clenbuterol (6 fold increase) than in control rats (2 fold increase), but absolute flow rates were still significantly lower in the rats treated chronically with clenbuterol. Skeletal muscle beta-adrenoceptor density and subtype were assessed from ligand binding and displacement studies using [3H]-dihydroalprenolol. Rats treated with clenbuterol for 18 days showed a 50% reduction in beta-receptor density, but the ratio of beta 1/beta 2-receptors was unaffected (15% beta 1/85% beta 2). The results indicate that, although clenbuterol produces acute increases in muscle blood flow, chronic treatment results in lower flow rates immediately (1 h) and 24 h after the previous injection. The attenuated response following chronic treatment is associated with a marked reduction in skeletal muscle beta-adrenoceptor density. The data suggest that any anabolic effects of clenbuterol on muscle which may require, or may be mediated by increases in blood supply, cannot be sustained by chronic treatment. Conversely, blood flow to white and brown adipose tissue would appear to be potentiated by chronic treatment, possibly reflecting increases in lipolytic and/or thermogenic activity.

Animals↗